Denmark’s largest health insurer drops weight-loss drug coverage as demand soars, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The growing popularity of costly new weight-loss drugs has prompted insurers and health authorities to reconsider whether they can subsidise anti-obesity medications, particularly since lifetime use might be required to keep lost weight off. Since the start of the year, the increase in subsidies for weight loss medicine has reached a level that makes it unsustainable for the company, the insurer said in a statement., The growing popularity of costly new weight-loss drugs has prompted insurers and health authorities to reconsider whether they can subsidise anti-obesity medications, particularly since lifetime use might be required to keep lost weight off. Since the start of the year, the increase in subsidies for weight loss medicine has reached a level that makes it unsustainable for the company, the insurer said in a statement., , Read More